Skip to content

Exogenous Ketone Supplementation and Exercise Performance

The Effect of Exogenous Ketone Supplementation on 20 km Time Trial and Wingate Performance in Recreationally Active Individuals

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03895892
Enrollment
20
Registered
2019-03-29
Start date
2019-05-15
Completion date
2019-12-31
Last updated
2019-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ketonemia, Ketosis

Brief summary

20 healthy recreationally active men and woman aged 18-35 will participate in the study. There will be three treatments involved: Caffeinated ketone supplements, non-caffeinated ketone supplement and water-placebo. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. The three main trials will be separated by at least 1 week. After providing the corresponding treatment, participants will be given 30 minutes and after, they will perform a standardized 10-minute warm-up, followed by the 20 km time trial and a 30-second all-out Wingate test.

Detailed description

Some researchers support that a state of ketosis, reached through the use of ketogenic diet, has the potential to improve athletic. To attain such state, individuals must restrict carbohydrate intake to a maximum of 50g/ day or 10% while keeping protein intake moderate. One of the biggest challenges to achieve and maintain ketosis is complying with the diet due to its restrictive nature. Consequently, manufacturers have developed supplements that can induce a state of ketosis acutely (\ 1 hour). Unfortunately, there is very little evidence supporting the use of these supplements to enhance athletic performance. Hyperketonemia (blood ketone concentration \> 0.2 Mm) seems to elevate the rate of utilization of ketone bodies. These changes in substrate utilization may allow athletes to preserve, something that would be advantageous for exercise performance. Ketone salts have been shown to elevate the concentration of ketones in blood and as such they may allow the body benefit from the apparent sparing of carbohydrates. Manufacturers now provide ketones salts combined with other ingredients such as caffeine. However it is unknown whether or not the addition of these ingredients has any positive or negative effect on athletic performance. Caffeine alone has been shown to improve athletic performance in several studies. Therefore, the purpose of this study is to compare the effectiveness of a caffeine free ketone salt supplement vs a caffeinated ketone salt supplement and their effects on a 20km time trial and a 30 second all-out Wingate test.

Interventions

BEHAVIORAL20 km time trial

20 km time trial cycling test will be conducted to measure the effect of different drinks on time

BEHAVIORALWingate test

30 second all-out effort on a bike will be conducted to measure the effect of different drinks on peak power output

DIETARY_SUPPLEMENTKetone/Caffeine

Dietary supplement containing ketone salts and caffeine

DIETARY_SUPPLEMENTKetone

Dietary supplement containing only ketone salts

DIETARY_SUPPLEMENTWater Placebo

Dietary supplement containing only water

Sponsors

Western University, Canada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Masking description

Participants and investigators will be blinded as an individual not involved in the project will assemble and distribute the treatment (drinks) according to a coding system that is kept confidential until the study is completed. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. taste and texture of treatments will be matched and will be distribute in opaque bottles to keep participant blinded

Intervention model description

This will be a double blind repeated measures cross over study. There will be three treatments involved: Caffeinated ketone supplements, non-caffeinated ketone supplement and water-placebo. Participants will complete the protocol three times and the treatment order will be systematically rotated to avoid any order effect. Design of the study is composed of two performance tests 30 minutes following supplementation. All participants will arrive in a fed state to the laboratory. the corresponding treatment will be provided and 30 minutes later, they will perform a 20 km time trial. 10 minutes after the time trial, participants will perform a 30 second all-out Wingate test.

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy male and female recreationally active individuals * aged 15-35 years * non regular caffeine users.

Exclusion criteria

* Smoker * Taking part in other research * Sedentary * For women, if they are pregnant or become pregnant during the study * Injury limiting exercise ability. * Have symptoms or take medication for respiratory disease * Have symptoms or take medication for cardiovascular disease * Have symptoms or take mediation for neuromuscular disease * Use heart rate or blood pressure medications * Use any medications with side effects of dizziness, lack of motor control, or slowed reaction time

Design outcomes

Primary

MeasureTime frameDescription
20 km time trial40 minutesparticipants will ride for 20 km on a stationary bike and time to complete distance will be measured.
Wingate test30 secondsparticipants will perform a ver short all-out effort on a stationary bike. peak power output and fatigue index will be measured.

Secondary

MeasureTime frameDescription
Blood Ketone1 hourblood ketones will be measured using ketone meter
Blood Lactate1 hourblood lactate will be measured using lactate meter
Rates of perceived exertion (RPE)1 hourRPE will be measured using Borg's scale (1= low - 10= high).

Countries

Canada

Contacts

Primary ContactPeter Lemon, PhD
plemon@uwo.ca519 6612111
Backup ContactManuel D Quinones, MSc
5196612111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026